Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.33 - $0.58 $257 - $451
-779 Reduced 0.83%
93,601 $35,000
Q4 2022

Feb 13, 2023

SELL
$0.33 - $12.0 $33 - $1,236
-103 Reduced 0.11%
94,380 $31,000
Q3 2022

Nov 14, 2022

SELL
$0.68 - $11.25 $3 - $56
-5 Reduced 0.01%
94,483 $71,000
Q2 2022

Aug 12, 2022

SELL
$0.81 - $3.43 $212,285 - $898,937
-262,081 Reduced 73.5%
94,488 $86,000
Q1 2022

May 13, 2022

SELL
$2.27 - $4.13 $65,491 - $119,154
-28,851 Reduced 7.49%
356,569 $1.23 Million
Q4 2021

Feb 08, 2022

SELL
$3.37 - $6.87 $58,648 - $119,558
-17,403 Reduced 4.32%
385,420 $1.51 Million
Q3 2021

Nov 15, 2021

SELL
$5.78 - $7.86 $140,459 - $191,005
-24,301 Reduced 5.69%
402,823 $2.7 Million
Q2 2021

Aug 13, 2021

BUY
$7.82 - $12.44 $466,126 - $741,511
59,607 Added 16.22%
427,124 $3.34 Million
Q1 2021

May 12, 2021

SELL
$9.33 - $14.05 $214,506 - $323,023
-22,991 Reduced 5.89%
367,517 $4.64 Million
Q4 2020

Feb 11, 2021

SELL
$8.48 - $12.23 $68,026 - $98,109
-8,022 Reduced 2.01%
390,508 $3.67 Million
Q3 2020

Nov 16, 2020

BUY
$9.99 - $14.41 $80,509 - $116,130
8,059 Added 2.06%
398,530 $4.35 Million
Q2 2020

Aug 14, 2020

BUY
$12.28 - $17.63 $1.39 Million - $2 Million
113,471 Added 40.96%
390,471 $5.39 Million
Q1 2020

May 14, 2020

BUY
$11.31 - $18.26 $324,698 - $524,226
28,709 Added 11.56%
277,000 $3.68 Million
Q4 2019

Feb 14, 2020

BUY
$6.44 - $14.21 $210,085 - $463,558
32,622 Added 15.13%
248,291 $3.47 Million
Q3 2019

Nov 13, 2019

BUY
$4.6 - $8.46 $199,911 - $367,663
43,459 Added 25.24%
215,669 $1.42 Million
Q2 2019

Aug 13, 2019

BUY
$5.83 - $8.42 $22,183 - $32,038
3,805 Added 2.26%
172,210 $1.44 Million
Q1 2019

May 13, 2019

BUY
$4.02 - $5.81 $10,966 - $15,849
2,728 Added 1.65%
168,405 $979,000
Q4 2018

Feb 12, 2019

BUY
$3.35 - $5.68 $206,413 - $349,978
61,616 Added 59.21%
165,677 $669,000
Q3 2018

Nov 14, 2018

BUY
$4.07 - $6.25 $27,810 - $42,706
6,833 Added 7.03%
104,061 $561,000
Q2 2018

Sep 18, 2018

SELL
$5.19 - $9.71 $8,797 - $16,458
-1,695 Reduced 1.71%
97,228 $509,000
Q2 2018

Aug 14, 2018

BUY
$5.19 - $9.71 $398,441 - $745,446
76,771 Added 346.56%
98,923 $517,000
Q1 2018

May 09, 2018

BUY
$8.0 - $12.96 $47,584 - $77,086
5,948 Added 36.71%
22,152 $177,000
Q4 2017

Feb 14, 2018

SELL
$7.04 - $11.31 $84 - $135
-12 Reduced 0.07%
16,204 $163,000
Q3 2017

Nov 13, 2017

BUY
$5.0 - $7.14 $81,080 - $115,782
16,216
16,216 $113,000

Others Institutions Holding MTEM

About Molecular Templates, Inc.


  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Market Cap $7.33M
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.